Pfizer CEO Albert Bourla joins Squawk on the Street to discuss the company’s up to $10 billion acquisition of Metsera, the competitive landscape in obesity drugs, and Pfizer’s strategy for clinical ...
“What does your husband do?” Undoubtedly the man who asked me thought it was a harmless question. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content.
Amid Novo Nordisk and Pfizer’s whiplash contest for obesity biotech Metsera, Novo’s CEO has, quite literally, told his company's rival to put its money where its mouth is. “Novo Nordisk and Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results